| PERIOD ENDING | 29-Mar-09 | 30-Mar-08 | 25-Mar-07 | | Total Revenue | 49,221 | 47,395 | 45,730 | | Cost of Revenue | 32,135 | 30,335 | 27,274 | | | Gross Profit | 17,086 | 17,060 | 18,456 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 9,299 | 8,942 | 9,251 | | Non Recurring | (441) |
-
|
-
| | Others | 809 | 797 | 1,044 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,419 | 7,321 | 8,161 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (35) | | Earnings Before Interest And Taxes | 7,419 | 7,321 | 8,126 | | Interest Expense |
-
|
-
| 1 | | Income Before Tax | 7,419 | 7,321 | 8,125 | | Income Tax Expense | 2,461 | 2,472 | 2,917 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,958 | 4,849 | 5,208 | | | Non-recurring Events | | Discontinued Operations | 2,524 | 1,706 | 335 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 7,482 | 6,555 | 5,543 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,482 | $6,555 | $5,543 |
|
0.13% Nasdaq 
Income Statement
